[Risk and causes of gastroesophageal bleeding in patients with liver cirrhosis].

BACKGROUND/AIM Variceal bleeding is the most life-threating complication in liver cirrhosis. The aim of this study was to analyze the sources of gastroesophageal bleeding in patients with liver cirrhosis and to ascertain the risk factors of bleeding from esophageal varices. METHODS This prospective study included 52 patients with liver cirrhosis and portal hypertension. Severity of liver dysfunction according to Child's classification, coagulation parameters, and endoscopic findings were analyzed. In patients with varices we analyzed the size, color, location of varices, and the presence of red signs. The varices were classified as small, medium and large. RESULTS Esophageal varices were found in 76.9% of the patients. Isolated varices were present in 36.6%, and associated with other findings in 40.3%. Small varices were present in 10%, medium in 25% and large in 65% patients. Of them 55% had variceal bleeding. Variceal bleeding was present in 50% of the patients with medium and in 65.38% of the patients with large varices. There was no bleeding in the patients with small varices. Endoscopy revealed red signs before bleeding in 85% of the patients with large varices. There was a higher incidence of variceal bleeding in the Child's group B. There were no significant differences (p > 0.05) in the coagulation parameters in patients with and without variceal bleeding. Rebleeding was present in 86.36% of the patients. Most of them (52.63%) were rebleeding between 7 weeks and 12 months after the first episode of variceal bleeding. In the patients with the most severe hepatocellular dysfunction (Child's group C) the period between the first bleeding and rebleeding was the shortest (mean, 20.8 days). CONCLUSION Our study revealed that esophageal varices are the most frequent sources of bleeding in the patients with liver cirrhosis. There is the association between the first bleeding and large varices and the red signs. Coagulation disorders and hepatic dysfunction were not related to the initial episode of variceal bleeding. The risk of early rebleeding was higher in the patients with severe hepatic dysfunction (Child's class C).

[1]  V. Paunescu,et al.  [Risk factors for the immediate outcome of gastrointestinal bleeding in patients with cirrhosis]. , 2004, Chirurgia.

[2]  M. Fallon,et al.  Cost-effectiveness of screening, surveillance, and primary prophylaxis strategies for esophageal varices , 2002, American Journal of Gastroenterology.

[3]  S. Sarin,et al.  A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices , 2002, American Journal of Gastroenterology.

[4]  K. Chayama,et al.  Incidence of the appearance of the red color sign on esophageal varices and its predictive factors: long-term observations of 359 patients with cirrhosis , 2001, Journal of Gastroenterology.

[5]  N. Grace Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee. , 1997, The American journal of gastroenterology.

[6]  O. Garden,et al.  Prophylactic treatment of patients with esophageal varices: Is it ever indicated? , 1994, World Journal of Surgery.

[7]  R. Franchis,et al.  Why do varices bleed? , 1992, Gastroenterology clinics of North America.

[8]  A. Burroughs,et al.  Prevention of variceal rebleeding. , 1992, Gastroenterology clinics of North America.

[9]  N. Soehendra,et al.  Prophylactic sclerosing of esophageal varices--results of a prospective controlled study. , 1986, Endoscopy.

[10]  L. Witzel,et al.  PROPHYLACTIC ENDOSCOPIC SCLEROTHERAPY OF OESOPHAGEAL VARICES A Prospective Controlled Study , 1985, The Lancet.

[11]  G. Garcia‐Tsao,et al.  Variceal hemorrhage. , 1995, Critical care clinics.

[12]  H. V. van Buuren,et al.  Prevention of recurrent variceal bleeding: non-surgical procedures. , 1985, Clinics in gastroenterology.

[13]  S. Sherlock,et al.  Diseases of the Liver and Biliary System , 1955 .